Eric S. Furfine
Vorstandsvorsitzender bei Mosaic Biosciences, Inc.
Profil
Eric S.
Furfine is currently the Co-CEO & Chief Scientific Officer at Mosaic Biosciences, Inc. and also holds the position of Director at Ingenia Therapeutics Inc. Previously, he worked as the Director-Biochemical Analytical Pharmacology at GlaxoSmithKline LLC and as the Vice President-PreClinical Development at Regeneron Pharmaceuticals, Inc. In addition, he served as the Chief Executive & Scientific Officer at ImmuneXcite, Inc. for a brief period in 2016.
Prior to that, he was the SVP-Research & Preclinical Development at Adnexus.
From 2014 to 2016, he held the role of Chief Scientific Officer at Sesen Bio, Inc. Dr. Furfine completed his undergraduate studies at Washington University in St. Louis and obtained a doctorate degree from Brandeis University.
Aktive Positionen von Eric S. Furfine
| Unternehmen | Position | Beginn |
|---|---|---|
Ingenia Therapeutics Inc.
 Ingenia Therapeutics Inc. Medical/Nursing ServicesHealth Services Ingenia Therapeutics, Inc. provides health care services. The company is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
Mosaic Biosciences, Inc.
 Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Mosaic Biosciences, Inc. provides commercial research and development services. It conducts research on synthetic materials that support native tissue regeneration. The firm's solutions are designed for application in wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers. The company was founded by Martin Stanton, Chris Bowman, Kristi S. Anseth and Peter Mariner in 2009 and is headquartered in Boulder, CO. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Eric S. Furfine
| Unternehmen | Position | Ende |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.02.2016 |
ImmuneXcite, Inc.
 ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology ImmuneXcite, Inc. operates as a biopharmaceutical company which develops monoclonal antibodies for cancer. The firm provides nivel immuno-incology technology platform, which leverages both the innate and adaptive immune responses to selectively treat a wide range of tumor types. The company was Ifat Rubin-Bejerano, Gerald R. Fink and Yaniv Bejerano and is headquartered in Waltham, MA. | Vorstandsvorsitzender | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Eric S. Furfine
| Brandeis University | Doctorate Degree |
| Washington University in St. Louis | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
ImmuneXcite, Inc.
ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology ImmuneXcite, Inc. operates as a biopharmaceutical company which develops monoclonal antibodies for cancer. The firm provides nivel immuno-incology technology platform, which leverages both the innate and adaptive immune responses to selectively treat a wide range of tumor types. The company was Ifat Rubin-Bejerano, Gerald R. Fink and Yaniv Bejerano and is headquartered in Waltham, MA. | Health Technology |
Ingenia Therapeutics Inc.
Ingenia Therapeutics Inc. Medical/Nursing ServicesHealth Services Ingenia Therapeutics, Inc. provides health care services. The company is headquartered in Cambridge, MA. | Health Services |
Mosaic Biosciences, Inc.
Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Mosaic Biosciences, Inc. provides commercial research and development services. It conducts research on synthetic materials that support native tissue regeneration. The firm's solutions are designed for application in wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers. The company was founded by Martin Stanton, Chris Bowman, Kristi S. Anseth and Peter Mariner in 2009 and is headquartered in Boulder, CO. | Commercial Services |
